News items related to: News
-
ITPC-LATCA filed an application for nullity of Doravirine’s patent in Honduras
ITPC-LATCA is the hub forLatin America and the Caribbean of the International Treatment Preparedness Coalition (ITPC). According to the latest...
-
MPP-Merck Molnupiravir License Reveals the Limits of Voluntary Measures During a Pandemic
On 27th October 2021, Merck Sharpe Dohme (MSD) and the Medicines Patent Pool (MPP) announced a voluntary licensing agreement covering...
-
Civil society raises awareness on molnupiravir overpricing in Thailand
MMA’s partner in Thailand, AIDS Access Foundation, along with six other civil society organizations, have sent a letter to the...
-
The first time a community-based organization in Georgia files an IP opposition
By July 9, 2021, a total of 8,911 HIV/AIDS cases have been registered in the Infectious Diseases, AIDS & Clinical...
-
The only sustainable future is one where everyone has access to affordable optimal treatment
________________________________________ Baktygul Israilova, 48, was diagnosed with HIV more than 10 years ago, when she was pregnant with her second...
-
Moldovan patients and CSOs stood against the patent monopoly on bedaquiline
In 2019, 1.4 million people died from tuberculosis (TB) – which is the leading cause of death among people living...
-
Access to optimal treatment for HIV in Kazakhstan: as prices go down, so does stigma
MMA’s campaign partner in Kazakhstan, Answer, focuses on reducing prices, and improving access to optimal treatment for HCV, viral hepatitis...
-
Brazilian House of Representatives approves bill to suspend patents: finally lives before profits?
Two months ago, the Brazilian Senate approved a law project bill (Law Project 12/21) that allows the country to expand...
-
Samarn: Activists fought for my right to survive – and won
“Back in 1994, when I was in my early 20s, I fell ill while doing construction work in Bangkok. That’s...
-
Thailand’s opposition against Gilead’s patent application: overcharging what?
Earlier this month, Thai civil society opposed Gilead’s Sciences’ patent application on remdesivir, which has been trialled in the treatment...
-
Treatment activists – here’s your campaign toolkit!
Intellectual property on essential medicines, vaccines and other health technologies affects us all. Where you live directly impacts on the...
-
Editorial corrections: Pfizer’s NYT advert
Pfizer made 9.6 billion in net profit last year alone – 2021 is set to be an even more lucrative...